Arthrogryposis Multiplex Congenita 2 Neurogenic Type (AMC2)

Arthrogryposis multiplex congenita (AMC) describes babies born with stiff joints (contractures) in at least two different body areas because the baby did not move enough in the womb. “Neurogenic type” means the main cause is a problem in the nerves or the spinal cord that control muscles. When nerves don’t work well, muscles don’t move and joints become fixed in bent or straight positions. AMCN2 is a rare subtype described in genetics databases and rare-disease registries; in some families it has been linked to mutations (for example, ERGIC1) and has features like elbow and knee contractures, reduced muscle reflexes, and signs of spinal motor-neuron involvement. Most care focuses on gentle stretching, splints, therapy, and selected surgeries to improve movement and independence. There is no single curative medicine; treatment is individualized and started early. Monarch Initiative+3PMC+3PMC+3 AMC happens when fetal movement is reduced; in neurogenic AMC the driver is the nervous system—brain, spinal cord (anterior horn cells), peripheral nerves, or neuromuscular junction. Conditions reported with neurogenic AMC include lower-extremity-dominant spinal muscular atrophy (SMALED), congenital hypomyelinating neuropathies, and several gene-defined syndromes. More than 400 genes across all AMC phenotypes have been reported; for AMCN2, ERGIC1 is one cited locus in disease ontologies, but overall the genetics are heterogeneous and evolving. Mouse Genome Informatics+3PMC+3ERN ITHACA+3

Arthrogryposis multiplex congenita 2, neurogenic type (AMC2) is a rare condition present at birth where many joints become fixed or very stiff (contractures). In the neurogenic type, the main problem starts in the nervous system—especially the motor nerve cells in the spinal cord (anterior horn cells) and certain motor centers in the brainstem. Because those nerve cells do not develop or function normally, the baby moves less in the womb, the muscles become thin and weak, and the joints get stuck in bent or straight positions. This leads to limited movement of the elbows, knees, wrists, ankles, fingers, and sometimes hips. AMC2 is usually autosomal recessive (both copies of a gene are affected). Research has linked AMC2 to harmful changes in the ERGIC1 gene on chromosome 5q35.1, which is involved in transport between the endoplasmic reticulum and Golgi inside cells. The condition is typically non-progressive after birth, but contractures and weakness can cause life-long physical challenges. informatics.jax.org+3Genetic Rare Disease Center+3Medscape+3

---

Other names

• AMC neurogenic type

• AMC2; AMCN

• Neurogenic arthrogryposis multiplex congenita

• Arthrogryposis multiplex congenita 2, neurogenic type (OMIM/ORDO terms)
  These names refer to the same rare disorder where joint contractures are due to a primary nerve problem rather than a primary muscle or connective-tissue problem. Orpha+2Monarch Initiative+2

---

Types

1. By distribution of contractures – mainly arms and legs (elbows/knees common), sometimes hands/feet and hips. This reflects which muscles lost innervation during fetal life. Genetic Rare Disease Center

2. Isolated AMC2 vs. syndromic forms – most AMC2 is isolated to the neuromuscular system; however, some reports note associated features like congenital heart disease in disease-ontology summaries. informatics.jax.org

3. Severity spectrum – from moderate stiffness with preserved function to severe fixed joints with major mobility limits; the condition itself is generally non-lethal and non-progressive after birth in the AMC2 subtype. Medscape

4. By genetic status – biallelic pathogenic variants in ERGIC1 (confirmed), or “unknown-gene” cases where the clinical pattern suggests neurogenic AMC but genetic testing is negative or not yet diagnostic. KEGG

---

Causes

In AMC2, “causes” mostly describe mechanisms that reduce fetal movement because of a nerve problem. The single most specific cause today is ERGIC1-related disease. Other listed items are established or plausible neurogenic contributors described for neurogenic arthrogryposis in medical references.

1. ERGIC1 gene mutations (autosomal recessive) – damaging variants disrupt intracellular protein trafficking in developing neurons, causing reduced motor neuron function and fetal hypokinesia (low movement). KEGG+1

2. Abnormal development of spinal anterior horn cells – fewer or unhealthy motor neurons mean weaker signals to muscles, leading to contractures before birth. Genetic Rare Disease Center

3. Abnormal development of brainstem motor nuclei – similar impact for cranial-innervated muscles that help posture and movement. Genetic Rare Disease Center

4. Neurogenic muscular atrophy – muscle wasting because the nerve input is poor; joints then stiffen. UniProt

5. Absence or reduction of muscle spindles (sensory organs in muscle) – reduces feedback needed for normal tone and movement during fetal life. informatics.jax.org

6. Spinal motor-neuron depletion – fewer motor units reduce fetal activity and promote contractures. informatics.jax.org

7. Neurodevelopmental brain abnormalities – some patients show cortical or structural brain differences on MRI that correlate with neurogenic AMC and low movement in utero. Pedneur

8. Autosomal recessive inheritance pattern – when both parents carry one faulty copy, a child can inherit both and be affected. This is a cause at the inheritance level. NCBI

9. Fetal akinesia sequence (neurogenic) – a cascade where nerve dysfunction leads to little movement, leading to contractures. (Mechanistic umbrella term.) Rare Diseases

10. Disrupted motor axon guidance/synapse formation (neurogenic hypothesis) – nerve-to-muscle connections don’t form normally, so muscle is under-used prenatally. (Inferred from neurogenic arthrogryposis frameworks.) Rare Diseases

11. Secondary myopathy from denervation – muscle changes happen because nerves are impaired first. UniProt

12. Possible congenital heart anomalies in some AMC2 reports – not causal to contractures, but co-occurring features indicating broader developmental impact. informatics.jax.org

13. Unknown genetic causes beyond ERGIC1 – many neurogenic AMC cases still lack a defined gene despite clear neurogenic features. Genetic Rare Disease Center

14. Modifier genes – other variants might worsen or lessen severity of contractures in ERGIC1 disease (scientific inference from variable expressivity across arthrogryposis). platform.opentargets.org

15. Prenatal environmental factors that amplify neurogenic weakness – anything further reducing fetal movement can worsen contractures, though the primary driver in AMC2 is neurogenic. (General AMC concept.) Rare Diseases

16. Impaired intracellular trafficking in neurons (ERGIC1 pathway) – cellular-level mechanism consistent with ERGIC1 biology. KEGG

17. Autonomic support deficits to developing muscle – less trophic support from nerves can contribute to muscle thinning in utero (neurogenic concept). UniProt

18. Denervation-driven joint capsule tightening – without movement, the joint capsule tightens and shortens, fixing the joint. (Core arthrogryposis mechanism.) Rare Diseases

19. Positional constraints that compound neurogenic hypokinesia – if space is limited, low movement from nerves plus tight space worsens stiffness (adjunct mechanism). Rare Diseases

20. Perinatal neurogenic injury (rare adjunct) – events around birth rarely explain congenital contractures but can compound existing neurogenic weakness noted prenatally. (Clinical inference across arthrogryposis literature.) Rare Diseases

---

Symptoms and signs

1. Stiff joints at birth (contractures) – one of the earliest findings; joints may be fixed in a bent or straightened position. Genetic Rare Disease Center

2. Elbow and knee contractures – especially common sites in AMC2. informatics.jax.org

3. Wrist and ankle stiffness – hands and feet can be curved or rotated and hard to move. Genetic Rare Disease Center

4. Finger contractures – difficulty straightening or bending fingers fully. Genetic Rare Disease Center

5. Hip involvement – hips may be stiff or dislocated due to limited fetal motion. Rare Diseases

6. Reduced muscle bulk (muscle wasting) – muscles look thin because nerves did not activate them normally in the womb. UniProt

7. Weakness around affected joints – children may struggle to lift limbs against gravity. (Neurogenic pattern.) Rare Diseases

8. Limited range of motion – joints move through a smaller arc than expected. Rare Diseases

9. Feeding or breathing challenges in severe cases – if trunk or jaw muscles are involved, early support may be needed. (General AMC guidance.) Rare Diseases

10. Normal feeling (sensation) usually – AMC2 is mainly a motor problem, so touch and pain sensation are often preserved. (Neurogenic motor emphasis.) Rare Diseases

11. Non-progressive course – stiffness tends not to worsen due to disease spread; challenges evolve with growth and use. Medscape

12. Possible heart findings (some reports) – a minority may have congenital heart disease per disease-ontology summaries. informatics.jax.org

13. Normal intelligence in most – unless broader brain development issues are present. (General AMC observation; neurogenic focus is motor.) Rare Diseases

14. Developmental delay in motor milestones – rolling, sitting, standing, and walking may be later because of stiffness and weakness. Rare Diseases

15. Pain from joint stress – older children and adults can develop discomfort due to altered joint mechanics. (General AMC clinical course.) Rare Diseases

---

Diagnostic tests

A) Physical examination

1. Newborn joint assessment – the clinician looks and gently moves every joint to map which ones are stiff and at what angles. This creates a baseline plan. Rare Diseases

2. Range-of-motion (ROM) measurement – using a goniometer, the team measures how far each joint can bend or straighten. It helps track progress over time. Rare Diseases

3. Muscle bulk and tone check – doctors look for thin muscles and test how tight or floppy they feel, supporting a neurogenic pattern when paired with weakness. UniProt

4. Spine and posture review – looking for scoliosis or trunk weakness that may affect breathing and sitting balance. Rare Diseases

5. Functional assessment – how the child feeds, breathes, sits, or moves; this guides therapy and bracing decisions. Rare Diseases

B) Manual tests

6. Manual muscle testing (age-appropriate) – gentle resistance testing grades strength around stiff joints; neurogenic weakness often shows. Rare Diseases

7. Contracture end-feel testing – clinicians feel where the joint “stops” to tell if the limit is from tight soft tissue versus joint shape. This directs therapy. Rare Diseases

8. Hand and foot alignment exam – manual correction testing (how much a clubfoot or wrist bend can be corrected by hand) predicts response to casting. Rare Diseases

9. Jaw opening and swallow checks – simple bedside tests to catch early feeding issues due to stiffness or weakness. Rare Diseases

10. Serial casting response checks – repeated gentle measurements during casting (e.g., Ponseti for clubfoot) document gains in ROM. Rare Diseases

C) Laboratory & pathological tests

11. Genetic testing panel/exome – looks for ERGIC1 variants first and other arthrogryposis genes; confirms autosomal recessive disease when positive. KEGG

12. Creatine kinase (CK) – usually normal or only mildly raised in neurogenic causes, helping separate from primary muscle disease. Rare Diseases

13. Muscle biopsy (select cases) – pathology may show absence of muscle spindles and denervation changes, supporting a neurogenic origin. informatics.jax.org

14. Nerve or skin biopsy (rarely) – specialized centers may look for nerve developmental anomalies when diagnosis remains unclear. Rare Diseases

15. Basic metabolic / infection screens (as needed) – rule out broader syndromes or metabolic causes when the picture is atypical. Rare Diseases

D) Electrodiagnostic tests

16. Electromyography (EMG) – records electrical activity in muscles; a neurogenic pattern (denervation) supports AMC2. Rare Diseases

17. Nerve conduction studies (NCS) – measure how fast and well nerves carry signals to muscles; neurogenic AMC may show reduced motor responses. Rare Diseases

18. Repetitive nerve stimulation (select cases) – used if there is a concern for disorders of neuromuscular transmission; usually normal in AMC2 but helps exclude mimics. Rare Diseases

E) Imaging tests

19. Prenatal ultrasound – can show reduced fetal movement and fixed joint positions; alerts the team before birth for planning. Cleveland Clinic

20. Prenatal MRI (if available) – offers a detailed look at fetal joints and soft tissues when ultrasound is uncertain. Cleveland Clinic

21. Postnatal MRI of spine and brain – may reveal developmental abnormalities (e.g., cortical or spinal changes) that fit a neurogenic cause. Pedneur

22. X-rays of affected joints – show alignment, dislocation (e.g., hips), and bone changes that help orthopedic planning. Rare Diseases

Non-pharmacological treatments (therapies & other care)

Evidence statement: Most benefit in AMC comes from early, skilled rehabilitation, orthoses, and targeted surgery; high-quality trials are limited, but consensus and cohort data support early, sustained, family-centered therapy. BioMed Central+2PMC+2

Below are 12 high-value interventions to start (I can expand to 20 with 150-word write-ups on request):

1. Early gentle stretching & range-of-motion (ROM) program
   Purpose: prevent worsening stiffness; maintain joint mobility. Mechanism: slow, repeated stretching remodels soft tissues and preserves joint play. Parents are trained to continue exercises at home daily. Medscape

2. Positioning & splinting (day/night resting splints)
   Purpose: hold joints in functional alignment and prevent contracture rebound. Mechanism: low-load, prolonged stretch using thermoplastic splints or soft casts. Medscape

3. Serial casting (especially feet/knees/elbows)
   Purpose: gradually correct deformities (e.g., clubfoot) without or before surgery. Mechanism: stepwise casts increase range safely over weeks. ERN ITHACA

4. Custom orthoses (AFOs, KAFOs, wrist/hand orthoses)
   Purpose: stability for standing/walking and hand function. Mechanism: external support optimizes lever arms and reduces energy cost. jposna.org

5. Task-oriented occupational therapy (OT) for self-care
   Purpose: improve independence in feeding, dressing, hygiene. Mechanism: practice of real-world tasks with adaptive strategies and tools. BioMed Central

6. Physical therapy (PT) for strengthening and gait training
   Purpose: build endurance and safe mobility; use walkers/crutches or wheelchairs as needed. Mechanism: progressive resistance (where innervation allows) and gait practice. PMC

7. Aquatic therapy
   Purpose: reduce joint load, allow freer motion, build confidence. Mechanism: buoyancy lessens gravity; warm water aids tissue extensibility. PMC

8. Adaptive equipment & assistive technology
   Purpose: enable school, play, and work (e.g., modified utensils, switches, powered mobility). Mechanism: ergonomic and powered aids bypass joint limits. jposna.org

9. Respiratory and swallowing support when indicated
   Purpose: protect lungs and nutrition if bulbar/respiratory muscles are weak. Mechanism: SLP assessment, safe-swallow plans, cough assist, or non-invasive ventilation where needed. ERN ITHACA

10. Pain management without medication
    Purpose: comfort during stretching/casting. Mechanism: heat/ice, pacing, relaxation, child-friendly distraction, and splinting adjustments. BioMed Central

11. Family education & home program
    Purpose: ensure daily therapy continues outside clinic; parents are key partners. Mechanism: teach safe stretching, splint care, and equipment use. BioMed Central

12. Psychosocial support & school integration
    Purpose: participation and mental well-being. Mechanism: counseling, Individualized Education Program (IEP), and peer inclusion strategies. BioMed Central

---

Medicines

Important: There is no disease-modifying drug for neurogenic AMC itself. Medications are used for symptoms (pain, spasticity if present, sleep, reflux/aspiration risk) or for associated diagnoses (e.g., SMA-related therapies in specific gene-defined conditions). All dosing must be individualized by the child’s clinician. Medscape+1

Examples of symptom-focused drug classes your care team may consider (evidence in AMC is extrapolated from general pediatric use):

1. Acetaminophen (paracetamol) – for procedural or musculoskeletal pain during stretching/casting; mechanism: central COX inhibition; typical pediatric dosing follows standard references and requires clinician guidance. Medscape

2. Ibuprofen or other NSAIDs – short-term pain/inflammation relief around casting or after surgery; monitor GI/renal risks. Medscape

3. Topical anesthetics (e.g., lidocaine/prilocaine) before procedures – reduce procedural discomfort. Medscape

4. Gabapentin (selected cases) – for neuropathic pain features (burning/tingling) where present; evidence specific to AMC is limited. BioMed Central

5. Antispasticity agents (e.g., baclofen, diazepam) – only if coexisting spasticity is documented; many AMC patients are not spastic (contractures are not the same as spasticity). Medscape

6. Botulinum toxin injections (selected patterns) – occasionally used to rebalance overactive antagonists before casting/splinting, but data in AMC are limited; careful specialist selection is needed. jposna.org

7. Acid-suppression and reflux management – for aspiration risk in bulbar weakness; chosen based on gastroenterology assessment. ERN ITHACA

8. SMA-specific therapies (if genetic diagnosis fits) – In rare neurogenic AMC linked to SMA spectrum (e.g., SMALED subtypes), disease-specific options may be discussed by neuromuscular specialists; this is genotype-dependent and not generalizable to AMCN2 without the matching gene. ScienceDirect

---

Dietary molecular supplements

Evidence statement: No dietary supplement has been shown to reverse neurogenic AMC. Nutrition still matters for growth, bone health, and healing. Any supplement plan should be overseen by pediatrics and nutrition. BioMed Central

Useful, general-health examples (not disease-modifying):

• Vitamin D & calcium for bone strength—important with reduced mobility and after orthopedic surgery. Mechanism: bone mineralization. SAGE Journals

• Adequate protein/energy intake to support muscle and surgical recovery; mechanism: provides amino acids and calories for tissue repair. SAGE Journals

• Omega-3 fatty acids for general anti-inflammatory effects (indirect comfort); AMC-specific data are lacking. PMC

(I can build a 10-item supplement section with 150-word safety notes if you’d like.)

---

Immunity boosters, regenerative drugs, and stem-cell therapies

There are no approved regenerative drugs or stem-cell treatments proven to treat AMCN2 or to reverse established joint contractures. Unproven “stem-cell” or “immune booster” products marketed online should be avoided outside regulated clinical trials. Management remains rehabilitation, orthoses, and selective surgery. BioMed Central+1

---

Surgeries

Surgery is individualized; timing and sequencing matter. The goals are to place joints in positions that allow care, mobility, and function, while minimizing the number of operations. ERN ITHACA+1

1. Clubfoot correction (Ponseti casting ± Achilles tenotomy; salvage osteotomies if rigid)
   Why: to achieve plantigrade, braceable feet for standing/walking. ERN ITHACA

2. Knee procedures (posterior releases for flexion contractures; distal femoral extension osteotomy for extension deformity)
   Why: to enable sitting, standing, and bracing. ERN ITHACA

3. Hip soft-tissue releases ± osteotomies (case-by-case for contracture/dislocation)
   Why: balance motion, improve sitting/standing comfort and hygiene. ERN ITHACA

4. Upper-limb tendon transfers and releases
   Why: position hands for feeding/hygiene; improve reach or hand-to-mouth. jposna.org

5. Spine surgery (if progressive scoliosis impairs sitting or lung function)
   Why: maintain posture and respiratory capacity when bracing fails. jposna.org

---

Practical prevention

These don’t prevent the condition, but they help prevent worsening and complications:

1. Start stretching and splinting early and follow the home plan daily. Medscape

2. Keep regular orthosis checks to adjust fit as the child grows. jposna.org

3. Use serial casting when recommended to gain motion safely. ERN ITHACA

4. Maintain bone health: vitamin D, calcium, safe weight-bearing/standing program. SAGE Journals

5. Protect skin under splints/casts; watch for pressure areas. Medscape

6. Keep vaccinations current and promote respiratory hygiene if bulbar weakness exists. ERN ITHACA

7. Encourage activity/play within ability to prevent deconditioning. PMC

8. Prepare for procedures with pain-reduction strategies (non-drug and drug as prescribed). Medscape

9. Plan school accommodations and assistive tech early. BioMed Central

10. Genetic counseling for families planning future pregnancies. BMJ Journals

---

When to see a doctor urgently

• New or rapidly worsening breathing, feeding, or choking episodes. ERN ITHACA

• Significant swelling, redness, or skin breakdown under a cast or splint. Medscape

• Fever with cough in a child with weak cough or bulbar issues. ERN ITHACA

• Sudden loss of mobility or severe, unrelieved pain. jposna.org

• Concerns about equipment fit or new pressure sores. jposna.org

---

What to eat & what to avoid

Eat more: protein-rich foods for healing (eggs, fish, legumes), calcium-rich foods (milk/yogurt, leafy greens), vitamin-D sources (fortified foods), fiber and fluids to prevent constipation from low activity or pain meds. Limit/avoid: sugary drinks and ultra-processed snacks (empty calories), excess salt (swelling), and any supplement not recommended by your doctor. Nutrition supports growth and recovery but does not “cure” AMCN2. SAGE Journals

---

FAQs

1) Is AMCN2 the same as “arthrogryposis”?
AMCN2 is one rare, neurogenic subtype under the broad AMC umbrella. AMC means multiple joint contractures at birth from too little fetal movement; AMCN2 means the main problem comes from nerves/spinal cord. PMC+1

2) What causes the lack of movement before birth?
In neurogenic forms, nerve signals to muscles are weak or absent, so muscles don’t move; joints stiffen in fixed positions. PMC

3) Can therapy really help?
Yes. Early, consistent stretching, splinting, and functional therapy are core treatments and improve day-to-day abilities. BioMed Central+1

4) Are there medicines that cure AMCN2?
No. Medicines help with pain, spasticity (if present), reflux, or associated conditions. Some gene-specific neuromuscular disorders have their own treatments, but these apply only when the genotype matches. Medscape+1

5) Will my child need surgery?
Many children benefit from targeted procedures for feet, knees, hips, hands, or spine to improve function and comfort, planned over time. ERN ITHACA+1

6) What is the long-term outlook?
Most adults with AMC are ambulatory, though many need help with self-care; outcomes vary with severity and access to early, expert care. jposna.org

7) Is intelligence affected?
Usually not, unless there is central nervous system syndrome involvement—which is present in a minority of AMC cases. ERN ITHACA

8) Should we get genetic testing?
Often yes, to clarify subtype, guide counseling, and sometimes tailor management. BMJ Journals

9) Are stem-cell treatments available?
No approved stem-cell therapies have been proven to treat AMCN2; beware unregulated offerings. BioMed Central

10) Can diet fix contractures?
No, but good nutrition supports growth, bones, and recovery from therapy/surgery. SAGE Journals

11) Is pain common?
Some children have discomfort with stretching, casting, or surgery—managed with non-drug strategies and short-term analgesics as prescribed. Medscape

12) What specialists are involved?
A coordinated team: pediatrics, PM&R, PT/OT/SLP, orthopedics, neurology, genetics, pulmonology, nutrition, and social work. BioMed Central

13) How often will we need new splints or braces?
Frequently during growth; they must be checked and adjusted to avoid pressure injuries and maintain function. jposna.org

14) Can children with AMCN2 go to regular school?
Yes—with accommodations, assistive tech, and therapy supports to maximize participation. BioMed Central

15) Where can families find reliable information?
Rare-disease registries and clinical reviews provide trustworthy summaries and care guidance. Rare Diseases +1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 23, 2025.